Cargando…
Management of metastatic renal cell carcinoma – mini review
The management of metastatic renal cell carcinoma (mRCC) has evolved considerably in the last decade. A number of different systemic molecular targeted agents that have been recently approved have improved the survival of patients with mRCC. This mini-review focuses on the implementation of multi-mo...
Autores principales: | Bharthuar, Anubha, Pandey, Himanshu, Sood, Swapan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Codon Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345543/ https://www.ncbi.nlm.nih.gov/pubmed/28326262 http://dx.doi.org/10.15586/jkcvhl.2015.28 |
Ejemplares similares
-
Metastatic renal cell carcinoma: Current scenario and future trends
por: Bharthuar, Anubha
Publicado: (2012) -
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
por: Rathi, Nityam, et al.
Publicado: (2020) -
Axitinib for the Management of Metastatic Renal Cell Carcinoma
por: Escudier, Bernard, et al.
Publicado: (2012) -
The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review
por: Wei, Shuanzeng, et al.
Publicado: (2017) -
Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
por: Vecchio, Sharon J. Del, et al.
Publicado: (2018)